SOL Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,098	Closed	-$1.96M	–	308
2025 Q4	$1.96M	Sell	16,098 -467	-3%	-$53.5K	0.18%	127
2025 Q3	$1.66M	Sell	16,565 -5,425	-25%	-$489K	0.15%	137
2025 Q2	$1.82M	Sell	21,990 -8,052	-27%	-$642K	0.18%	124
2025 Q1	$2.44M	Sell	30,042 -842	-3%	-$75.3K	0.27%	96
2024 Q4	$2.78M	Sell	30,884 -1,221	-4%	-$118K	0.31%	89
2024 Q3	$3.17M	Buy	32,105 +165	+0.5%	+$16.2K	0.35%	78
2024 Q2	$2.96M	Buy	31,940 +174	+0.5%	+$15.6K	0.36%	78
2024 Q1	$3.01M	Buy	31,766 +7,570	+31%	+$702K	0.38%	80
2023 Q4	$2.16M	Buy	24,196 +13,865	+134%	+$1.03M	0.29%	100
2023 Q3	$754K	Buy	10,331 +4,368	+73%	+$349K	0.12%	168
2023 Q2	$496K	Buy	5,963 +1,078	+22%	+$90.2K	0.08%	203
2023 Q1	$372K	Buy	4,885 +350	+8%	+$29K	0.06%	228
2022 Q4	$376K	Buy	4,535 +895	+25%	+$72.5K	0.07%	218
2022 Q3	$289K	Buy	3,640 +290	+9%	+$24.4K	0.06%	225
2022 Q2	$249K	Buy	3,350 +600	+22%	+$45K	0.05%	234
2022 Q1	$247K	Buy	2,750 +850	+45%	+$78.5K	0.04%	243
2021 Q4	$213K	Buy	1,900 +200	+12%	+$24.1K	0.04%	249
2021 Q3	$214K	Hold	1,700	–	–	0.04%	237
2021 Q2	$230K	Hold	1,700	–	–	0.05%	238
2021 Q1	$231K	Hold	1,700	–	–	0.05%	225
2020 Q4	$239K	Buy	+1,700	New	+$218K	0.06%	216